Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2020

01-12-2020 | Isoniazid | Research article

Impact of emphysema on sputum culture conversion in male patients with pulmonary tuberculosis: a retrospective analysis

Authors: Naoki Takasaka, Yoshitaka Seki, Ikumi Fujisaki, Shota Uchiyama, Sachi Matsubayashi, Akihito Sato, Yumie Yamanaka, Kyuto Odashima, Taisuke Kazuyori, Aya Seki, Hiroshi Takeda, Takeo Ishikawa, Kazuyoshi Kuwano

Published in: BMC Pulmonary Medicine | Issue 1/2020

Login to get access

Abstract

Background

Although cigarette smoking may have a negative impact on the clinical outcome of pulmonary tuberculosis (PTB), few studies have investigated the impact of smoking-associated lung diseases. Emphysema is a major pathological finding of smoking-related lung damage. We aimed to clarify the effect of emphysema on sputum culture conversion rate for Mycobacterium tuberculosis (MTB).

Methods

We retrospectively studied 79 male patients with PTB confirmed by acid-fast bacillus smear and culture at Jikei University Daisan Hospital between January 2015 and December 2018. We investigated the sputum culture conversion rates for MTB after starting standard anti-TB treatment in patients with or without emphysema. Emphysema was defined as Goddard score ≥ 1 based on low attenuation area < − 950 Hounsfield Unit (HU) using computed tomography (CT). We also evaluated the effect on PTB-related CT findings prior to anti-TB treatment.

Results

Mycobacterial median time to culture conversion (TCC) in 38 PTB patients with emphysema was 52.0 days [interquartile range (IQR) 29.0–66.0 days], which was significantly delayed compared with that in 41 patients without emphysema (28.0 days, IQR 14.0–42.0 days) (p < 0.001, log-rank test). Multivariate Cox proportional hazards analysis showed that the following were associated with delayed TCC: emphysema [hazard ratio (HR): 2.43; 95% confidence interval (CI): 1.18–4.97; p = 0.015), cavities (HR: 2.15; 95% CI: 1.83–3.89; p = 0.012) and baseline time to TB detection within 2 weeks (HR: 2.95; 95% CI: 1.64–5.31; p < 0.0001). Cavities and consolidation were more often identified by CT in PTB patients with than without emphysema (71.05% vs 43.90%; p = 0.015, and 84.21% vs 60.98%; p = 0.021, respectively).

Conclusions

This study suggests that emphysema poses an increased risk of delayed TCC in PTB. Emphysema detection by CT might be a useful method for prediction of the duration of PTB treatment required for sputum negative conversion.
Literature
3.
go back to reference Mitchison DA. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am Rev Respir Dis. 1993;147:1062–3.CrossRefPubMed Mitchison DA. Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months. Am Rev Respir Dis. 1993;147:1062–3.CrossRefPubMed
4.
go back to reference Kanda R, Nagao T, Tho NV, et al. Factors affecting time to sputum culture conversion in adults with pulmonary tuberculosis: a historical cohort study without censored cases. PLoS One. 2015;10:e0142607.CrossRefPubMedPubMedCentral Kanda R, Nagao T, Tho NV, et al. Factors affecting time to sputum culture conversion in adults with pulmonary tuberculosis: a historical cohort study without censored cases. PLoS One. 2015;10:e0142607.CrossRefPubMedPubMedCentral
6.
go back to reference Reimann M, Schaub D, Kalsdorf B, et al. Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB. Int J Tuberc Lung Dis. 2019;23:93–8.CrossRefPubMed Reimann M, Schaub D, Kalsdorf B, et al. Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB. Int J Tuberc Lung Dis. 2019;23:93–8.CrossRefPubMed
7.
go back to reference Craig JM, Scott AL, Mitzner W. Immune-mediated inflammation in the pathogenesis of emphysema: insights from mouse models. Cell Tissue Res. 2017;367:591–605.CrossRefPubMedPubMedCentral Craig JM, Scott AL, Mitzner W. Immune-mediated inflammation in the pathogenesis of emphysema: insights from mouse models. Cell Tissue Res. 2017;367:591–605.CrossRefPubMedPubMedCentral
8.
go back to reference Byrne AJ, Mathie SA, Gregory LG, et al. Pulmonary macrophages: key players in the innate defence of the airways. Thorax. 2015;70:1189–96.CrossRefPubMed Byrne AJ, Mathie SA, Gregory LG, et al. Pulmonary macrophages: key players in the innate defence of the airways. Thorax. 2015;70:1189–96.CrossRefPubMed
9.
go back to reference Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27.CrossRefPubMed Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138:16–27.CrossRefPubMed
10.
go back to reference Taylor AE, Finney-Hayward TK, Quint JK, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J. 2010;35:1039–47.CrossRefPubMed Taylor AE, Finney-Hayward TK, Quint JK, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J. 2010;35:1039–47.CrossRefPubMed
11.
go back to reference Galbán CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18:1711–5.CrossRefPubMedPubMedCentral Galbán CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18:1711–5.CrossRefPubMedPubMedCentral
12.
go back to reference Ostridge K, Williams N, Kim V, et al. Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases. Respir Res. 2016;17:92.CrossRefPubMedPubMedCentral Ostridge K, Williams N, Kim V, et al. Distinct emphysema subtypes defined by quantitative CT analysis are associated with specific pulmonary matrix metalloproteinases. Respir Res. 2016;17:92.CrossRefPubMedPubMedCentral
13.
go back to reference Castaldi PJ, Estépar RSJ, Mendoza CS, et al. Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers. Am J Respir Crit Care Med. 2013;188:1083–90.CrossRefPubMedPubMedCentral Castaldi PJ, Estépar RSJ, Mendoza CS, et al. Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers. Am J Respir Crit Care Med. 2013;188:1083–90.CrossRefPubMedPubMedCentral
14.
go back to reference Smith BM, Austin JH, Newell JD, et al. Pulmonary emphysema subtypes on computed tomography: the MESA COPD study. Am J Med. 2014;127:94.e7–23.CrossRef Smith BM, Austin JH, Newell JD, et al. Pulmonary emphysema subtypes on computed tomography: the MESA COPD study. Am J Med. 2014;127:94.e7–23.CrossRef
15.
go back to reference Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med. 2012;161:1376–95. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am J Respir Crit Care Med. 2012;161:1376–95.
16.
go back to reference Dorman SE, Johnson JL, Goldberg S, et al. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med. 2009;180:273–80.CrossRefPubMed Dorman SE, Johnson JL, Goldberg S, et al. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis. Am J Respir Crit Care Med. 2009;180:273–80.CrossRefPubMed
18.
go back to reference Jeon KN, Ha JY, Park MJ, et al. Pulmonary tuberculosis in patients with emphysema. J Comput Assist Tomogr. 2016;40:912–6.CrossRefPubMed Jeon KN, Ha JY, Park MJ, et al. Pulmonary tuberculosis in patients with emphysema. J Comput Assist Tomogr. 2016;40:912–6.CrossRefPubMed
19.
go back to reference Song JW, Koh W-JJ, Lee KS, et al. High-resolution CT findings of Mycobacterium avium-intracellulare complex pulmonary disease: correlation with pulmonary function test results. AJR Am J Roentgenol. 2008;191:W160.CrossRefPubMed Song JW, Koh W-JJ, Lee KS, et al. High-resolution CT findings of Mycobacterium avium-intracellulare complex pulmonary disease: correlation with pulmonary function test results. AJR Am J Roentgenol. 2008;191:W160.CrossRefPubMed
20.
go back to reference Gevenois PA, de Maertelaer V, Vuyst PD, et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1995;152:653–7.CrossRefPubMed Gevenois PA, de Maertelaer V, Vuyst PD, et al. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1995;152:653–7.CrossRefPubMed
21.
go back to reference Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33:379–87.CrossRefPubMed Goddard PR, Nicholson EM, Laszlo G, et al. Computed tomography in pulmonary emphysema. Clin Radiol. 1982;33:379–87.CrossRefPubMed
22.
go back to reference Makino Y, Shimada Y, Hagiwara M, et al. Assessment of emphysema severity as measured on three-dimensional computed tomography images for predicting respiratory complications after lung surgery. Eur J Cardiothorac Surg. 2018;54:671–6.CrossRefPubMed Makino Y, Shimada Y, Hagiwara M, et al. Assessment of emphysema severity as measured on three-dimensional computed tomography images for predicting respiratory complications after lung surgery. Eur J Cardiothorac Surg. 2018;54:671–6.CrossRefPubMed
23.
go back to reference Ueda K, Jinbo M, Li T-SS, et al. Computed tomography-diagnosed emphysema, not airway obstruction, is associated with the prognostic outcome of early-stage lung cancer. Clin Cancer Res. 2006;12:6730–6.CrossRefPubMed Ueda K, Jinbo M, Li T-SS, et al. Computed tomography-diagnosed emphysema, not airway obstruction, is associated with the prognostic outcome of early-stage lung cancer. Clin Cancer Res. 2006;12:6730–6.CrossRefPubMed
24.
go back to reference Lee HY, Kim EY, Kim YS, et al. Prognostic significance of CT-determined emphysema in patients with small cell lung cancer. J Thorac Dis. 2018;10:874–81.CrossRefPubMedPubMedCentral Lee HY, Kim EY, Kim YS, et al. Prognostic significance of CT-determined emphysema in patients with small cell lung cancer. J Thorac Dis. 2018;10:874–81.CrossRefPubMedPubMedCentral
25.
go back to reference Kim Y, Kim E, Ahn H, et al. Prognostic significance of CT-emphysema score in patients with advanced squamous cell lung cancer. J Thorac Dis. 2016;8:1966–73.CrossRefPubMedPubMedCentral Kim Y, Kim E, Ahn H, et al. Prognostic significance of CT-emphysema score in patients with advanced squamous cell lung cancer. J Thorac Dis. 2016;8:1966–73.CrossRefPubMedPubMedCentral
26.
go back to reference Makita H, Nasuhara Y, Nagai K, et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007;62:932–7.CrossRefPubMedPubMedCentral Makita H, Nasuhara Y, Nagai K, et al. Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax. 2007;62:932–7.CrossRefPubMedPubMedCentral
27.
go back to reference Lin H-HH, Ezzati M, Chang H-YY, et al. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med. 2009;180:475–80.CrossRefPubMed Lin H-HH, Ezzati M, Chang H-YY, et al. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med. 2009;180:475–80.CrossRefPubMed
30.
go back to reference Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378:1015–26.CrossRefPubMed Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378:1015–26.CrossRefPubMed
31.
go back to reference Russell RE, Thorley A, Culpitt SV, et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol. 2002;283:L867–73.CrossRefPubMed Russell RE, Thorley A, Culpitt SV, et al. Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol. 2002;283:L867–73.CrossRefPubMed
32.
go back to reference Jones BE, Ryu R, Yang Z, et al. Chest radiographic findings in patients with tuberculosis with recent or remote infection. Am J Respir Crit Care Med. 1997;156:1270–3.CrossRefPubMed Jones BE, Ryu R, Yang Z, et al. Chest radiographic findings in patients with tuberculosis with recent or remote infection. Am J Respir Crit Care Med. 1997;156:1270–3.CrossRefPubMed
33.
go back to reference Canetti G. Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis. 1965;92:687–703.PubMed Canetti G. Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis. 1965;92:687–703.PubMed
34.
go back to reference Kosaka N, Sakai T, Uematsu H, et al. Specific high-resolution computed tomography findings associated with sputum smear-positive pulmonary tuberculosis. J Comput Assist Tomogr. 2005;29:801–4.CrossRefPubMed Kosaka N, Sakai T, Uematsu H, et al. Specific high-resolution computed tomography findings associated with sputum smear-positive pulmonary tuberculosis. J Comput Assist Tomogr. 2005;29:801–4.CrossRefPubMed
Metadata
Title
Impact of emphysema on sputum culture conversion in male patients with pulmonary tuberculosis: a retrospective analysis
Authors
Naoki Takasaka
Yoshitaka Seki
Ikumi Fujisaki
Shota Uchiyama
Sachi Matsubayashi
Akihito Sato
Yumie Yamanaka
Kyuto Odashima
Taisuke Kazuyori
Aya Seki
Hiroshi Takeda
Takeo Ishikawa
Kazuyoshi Kuwano
Publication date
01-12-2020

Other articles of this Issue 1/2020

BMC Pulmonary Medicine 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.